NAVB
RhumbLine Advisers’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-163,942
| Closed | -$155K | – | 3055 |
|
|
2016
Q1 | $155K | Buy |
163,942
+3,460
| +2% | +$3.27K | ﹤0.01% | 2811 |
|
|
2015
Q4 | $213K | Buy |
160,482
+12,525
| +8% | +$16.6K | ﹤0.01% | 2766 |
|
|
2015
Q3 | $337K | Buy |
147,957
+6,156
| +4% | +$14K | ﹤0.01% | 2466 |
|
|
2015
Q2 | $228K | Sell |
141,801
-9,455
| -6% | -$15.2K | ﹤0.01% | 2817 |
|
|
2015
Q1 | $240K | Buy |
151,256
+24,400
| +19% | +$38.7K | ﹤0.01% | 2736 |
|
|
2014
Q4 | $240K | Buy |
126,856
+6,775
| +6% | +$12.8K | ﹤0.01% | 2699 |
|
|
2014
Q3 | $159K | Hold |
120,081
| – | – | ﹤0.01% | 2836 |
|
|
2014
Q2 | $178K | Buy |
120,081
+14,050
| +13% | +$20.8K | ﹤0.01% | 2875 |
|
|
2014
Q1 | $196K | Sell |
106,031
-5,590
| -5% | -$10.3K | ﹤0.01% | 2780 |
|
|
2013
Q4 | $231K | Sell |
111,621
-2,400
| -2% | -$4.97K | ﹤0.01% | 2741 |
|
|
2013
Q3 | $302K | Sell |
114,021
-679
| -0.6% | -$1.8K | ﹤0.01% | 2521 |
|
|
2013
Q2 | $306K | Buy |
+114,700
| New | +$306K | ﹤0.01% | 2625 |
|